|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 9/16 | |||
| A61K 45/06 | |||
| A61K 31/138 | |||
| A61K 31/439 |
| (11) | Number of the document | 2836204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13720813.8 |
| Date of filing the European patent application | 2013-04-11 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/057555 |
| Date | 2013-04-11 |
| (87) | Number | WO 2013/153146 |
| Date | 2013-10-17 |
| (30) | Number | Date | Country code |
| 201261623672 P | 2012-04-13 | US | |
| 201361774698 P | 2013-03-08 | US |
| (72) |
VAN OORT, Michiel Mary, US
HONG, John N, US
|
| (73) |
GlaxoSmithKline Intellectual Property Development Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
| (54) | AGGREGATE PARTICLES |
| AGGREGATE PARTICLES |